NCT06996496

Brief Summary

The goal of this clinical trial is to learn if an educational tool helps postpartum patients after having high blood pressure during their pregnancy. The main question it aims to answer is: Does receiving this educational tool improve patient activation in the postpartum period? Researchers will compare a group of postpartum patients who get the tool 0-2 weeks after delivery with patients who do not get the tool to see if there is a difference in their activation scores 4-12 weeks later. Participants will: Complete a survey at first contact with study staff Complete a similar follow-up survey 4-12 weeks later

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Sep 2024Aug 2026

Study Start

First participant enrolled

September 18, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 30, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 2, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

12 months

First QC Date

May 20, 2025

Last Update Submit

September 18, 2025

Conditions

Keywords

hypertension, pregnancy inducedpatient satisfactionmaternal healthpostpartum periodcardiovascular diseaseshypertension

Outcome Measures

Primary Outcomes (1)

  • patient activation measure

    Patient Activation Measure (PAM)-13 questionnaire. Range is 0-100, with higher scores representing higher patient activation.

    From enrollment to 4-12 weeks after initial contact

Study Arms (2)

Postpartum patients after hypertensive disorders of pregnancy exposed to an educational tool

EXPERIMENTAL

Postpartum patients after hypertensive disorders of pregnancy exposed to an educational tool

Other: Postpartum educational tool after hypertensive pregnancy

Postpartum patients after hypertensive disorders of pregnancy not exposed to an educational tool

NO INTERVENTION

Postpartum patients after hypertensive disorders of pregnancy not exposed to an educational tool

Interventions

postpartum educational tool for patients having experienced a hypertensive disorder of pregnancy

Postpartum patients after hypertensive disorders of pregnancy exposed to an educational tool

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinical diagnosis of a hypertensive disorder of pregnancy, defined as having blood pressure reading greater than 130/80
  • be postpartum
  • or older at the time of enrollment
  • able to speak, read, and understand English or Spanish.

You may not qualify if:

  • no clinical diagnosis of hypertension before, during, or after their pregnancy defined as having blood pressure reading greater than 130/80
  • under the age of 18
  • only able to speak and read in a language other than English or Spanish
  • unable to legally consent to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Related Links

MeSH Terms

Conditions

Hypertension, Pregnancy-InducedPatient SatisfactionCardiovascular DiseasesHypertension

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVascular DiseasesTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Ann Celi, MD, MPH

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Physician

Study Record Dates

First Submitted

May 20, 2025

First Posted

May 30, 2025

Study Start

September 18, 2024

Primary Completion

September 2, 2025

Study Completion (Estimated)

August 1, 2026

Last Updated

September 23, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

This is a fundamentally a quality improvement initiative to improve iterative changes to an educational tool

Locations